Join
Live feed
·
PRReleasevia Quantisnow
Oramed Pharmaceuticals Inc. logo

Oramed Releases Letter to Shareholders, Highlighting Developments in its Oral Insulin Program, Significant Investment Appreciation, and Upcoming Growth Initiatives

ByQuantisnow·Wall Street's wire, on your screen.
ORMP· Oramed Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ORMP (Oramed Pharmaceuticals Inc.) and more on Quantisnow.